Q2 2020 Xencor Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to the Second Quarter 2020 Xencor Conference Call. (Operator Instructions)
Now I would like to turn the call to your speaker today, Charles Liles, Head of Investor Relations.
Thank you and good afternoon.
Earlier today, we issued a press release which outlines the topics we plan to discuss today. The press release is available at www.xencor.com. Today on our call, Bassil Dahiyat, President and Chief Executive Officer, will provide updates regarding COVID-19 and our partnerships; Allen Yang, Chief Medical Officer, will review recently presented clinical data; John Desjarlais, Chief Scientific Officer, will provide updates from preclinical development; and John Kuch, Chief Financial Officer, will review financial results. And then we will open up the call for your questions.
Before we begin, I would
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |